Literature DB >> 30069377

Application of triple-chimney technique using C-TAG and Viabahn or Excluder iliac extension in TEVAR treatment of aortic arch dilation diseases.

Lixin Wang1,2,3, Yulong Huang3, Daqiao Guo1,2, Xin Xu1,2, Bin Chen1,2, Junhao Jiang1,2, Jue Yang1,2, Zhenyu Shi1,2, Ting Zhu1,2, Zhihui Dong1,2, Yun Shi1,2, Xiao Tang1,2, Jianing Yue1,2, Xiang Hong1,3, Gang Chen1,3, Yihui Chen1,3, Xiushi Zhou1,2, Weiguo Fu1,2,3, Yuqi Wang1,2.   

Abstract

BACKGROUND: To report the experience of a single centre regarding the application of the triple-chimney technique using C-TAG with Viabahn or Excluder iliac extension devices for the endovascular management of aortic arch dilation diseases.
METHODS: From July 2016 to August 2017, 7 patients (5 men; mean age 56.1±10.8 years) with aortic arch dilation diseases were treated with the triple-chimney technique. All patients were followed up at 1, 3, and 6 months and every 6 months thereafter.
RESULTS: Six innominate arteries were deployed with Excluder iliac extensions and one with a Viabahn cover-stent. All the left common carotid arteries and left subclavian arteries were placed with Viabahn. Reverse chimney technique was applied in four patients. Three (42.0%) type I endoleaks were found on the final angiogram. Two were apparently reduced, and one disappeared after balloon dilation. The mean follow-up time was 15.7 months (9-20 months). All the type I endoleak was found disappeared within 3 months. One patient died of myocardial infarction at 6 months after discharge. No other complications such as stent-graft migration, occlusion, type II endoleak or neurological stroke occurred.
CONCLUSIONS: The use of C-TAG coupled with Viabahn or Excluder iliac extension is feasible and effective for the treatment of aortic arch dilatation diseases. However, more patients and longer follow-up time are required to verify its long-term safety and efficacy.

Entities:  

Keywords:  Aortic arch; aortic dissection; chimney; snorkel; stent-graft; thoracic aortic aneurysm; thoracic endovascular aortic repair (TEVAR)

Year:  2018        PMID: 30069377      PMCID: PMC6051863          DOI: 10.21037/jtd.2018.06.105

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  35 in total

1.  Endovascular aortic repair combined with chimney technique in the treatment of stanford type B aortic dissection involving aortic arch.

Authors:  Hong Liu; Chang Shu; Xin Li; Tun Wang; Ming Li; Quan-Ming Li; Kun Fang; Shalong Wang
Journal:  Ann Vasc Surg       Date:  2015-02-23       Impact factor: 1.466

2.  Endovascular debranching of the aortic arch during thoracic endograft repair.

Authors:  Giancarlo Cires; Robert E Noll; Francisco C Albuquerque; Britt H Tonnessen; W Charles Sternbergh
Journal:  J Vasc Surg       Date:  2011-04-16       Impact factor: 4.268

3.  Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial.

Authors:  Joseph E Bavaria; Jehangir J Appoo; Michel S Makaroun; Joel Verter; Zi-Fan Yu; R Scott Mitchell
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01-08       Impact factor: 5.209

4.  How to size the main aortic endograft in a chimney procedure.

Authors:  Heng-Wen Chou; Chih-Yang Chan; Shoei-Shen Wang; I-Hui Wu
Journal:  J Thorac Cardiovasc Surg       Date:  2013-12-09       Impact factor: 5.209

5.  Thoracic Endovascular Aortic Repair of Aortic Arch Pathologies with the Conformable Thoracic Aortic Graft: Early and 2 year Results from a European Multicentre Registry.

Authors:  D Böckler; J Brunkwall; P R Taylor; N Mangialardi; J Hüsing; T Larzon
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-04-20       Impact factor: 7.069

6.  Intentional coverage of the left subclavian artery during endovascular stent graft repair for thoracic aortic disease.

Authors:  R Caronno; G Piffaretti; M Tozzi; C Lomazzi; N Rivolta; P Castelli
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

7.  Left subclavian artery coverage during thoracic endovascular aortic repair and risk of perioperative stroke or death.

Authors:  Jayer Chung; Karthikeshwar Kasirajan; Ravi K Veeraswamy; Thomas F Dodson; Atef A Salam; Elliot L Chaikof; Matthew A Corriere
Journal:  J Vasc Surg       Date:  2011-06-12       Impact factor: 4.268

8.  Technical advances in total aortic arch replacement.

Authors:  Justus T Strauch; David Spielvogel; Alexander Lauten; Jan D Galla; Steven L Lansman; Kirk McMurtry; Randall B Griepp
Journal:  Ann Thorac Surg       Date:  2004-02       Impact factor: 4.330

9.  Utility of left subclavian artery revascularization in association with endoluminal repair of acute and chronic thoracic aortic pathology.

Authors:  Brian G Peterson; Mark K Eskandari; Thomas G Gleason; Mark D Morasch
Journal:  J Vasc Surg       Date:  2006-03       Impact factor: 4.268

Review 10.  Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results.

Authors:  Stewart R Walsh; Tjun Y Tang; Umar Sadat; Jag Naik; Michael E Gaunt; Jonathan R Boyle; Paul D Hayes; Kevin Varty
Journal:  J Vasc Surg       Date:  2008-02-01       Impact factor: 4.268

View more
  3 in total

1.  Endovascular treatment of the dissected proximal aortic arch: a systematic review.

Authors:  Changtian Wang; Ludwig Karl von Segesser; Denis Berdajs; Enrico Ferrari
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

2.  Endovascular aortic repairs combined with looping-chimney technique for repairing aortic arch lesions and reconstructing left common carotid artery.

Authors:  Jinhui Zhang; Xunqiang Liu; Min Tian; Huanjun Chen; Jifeng Wang; Min Ji; Lei Cong; Chunxin Yang; Enshuai Zhu; Jing Tan
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

3.  Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center study.

Authors:  Tomoaki Kudo; Toru Kuratani; Kazuo Shimamura; Yoshiki Sawa
Journal:  JTCVS Tech       Date:  2020-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.